| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
Figure 2. The percentage of patients (y-axis) who lost 3 and
6 at 12 months following treatment as distributed among the various treatment groups (x-axis). Overall, 18% of patients lost
3 lines of VA and 10% lost
6 lines. The VA remained within ±3 lines of the baseline value in 82% of patients.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |